Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration (C9orf72 repeat analysis, for patients 18 years and older)
Use
This test analyzes the hexanucleotide (GGGGCC) repeat expansion in the C9orf72 gene, which is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Normal alleles have 24 or fewer repeats, disease-associated expansions are 60 or greater, and 25–59 repeats are of uncertain clinical significance. Clinical sensitivity varies by phenotype: up to 50% of ALS, 29% of FTLD, and 88% of combined cases carry expansions. Penetrance is age‑dependent, approaching nearly 100% by age 80, but reduced penetrance has been observed. Southern blot is not performed for alleles larger than 145 repeats. Samples from individuals under age 18 are not accepted per professional guidelines.
Special Instructions
Not provided.
Limitations
This assay cannot size alleles larger than 145 repeats and does not include Southern blot confirmation for those larger expansions. Repeat‑primed PCR may fail in rare cases with indels downstream of the repeat region. Somatic mosaicism or lab artifacts such as blood transfusion or hematologic neoplasm may affect results. Reduced penetrance and lack of correlation between repeat size and age of onset limit prognostic interpretation. Negative result does not rule out mosaic expansion in untested tissues.
Methodology
PCR-based (PCR)
Biomarkers
C9orf72
Gene
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Not provided
Minimum Volume
Not provided
Other tests from different labs that may be relevant